Regulation 2 Amendment of the Misuse of Drugs Regulations (Northern Ireland) 2002

(1)

The following amendments are made to Schedule 1 to the Misuse of Drugs Regulations (Northern Ireland) 2002^f1 (which specifies controlled drugs that are subject to the requirements of regulations 14, 15, 16, 18, 19, 20, 23, 26 and 27 of those Regulations).

(2)

In paragraph 1(a)—

(a)

after “Etryptamine” insert “Flualprazolam (8-chloro-6-(2-fluorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine)”;

(b)

after “Flubromazolam (8-Bromo-6-(2-fluorophenyl)-1-methyl-4H -[1,2,4]triazolo[4,3-a][1,4] benzodiazepine)” insert “Flunitrazolam (6-(2-fluorophenyl)-1-methyl-8-nitro-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine)”;

(c)

after “Nitrazolam (1-Methyl-8-nitro-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine)” insert “Norfludiazepam (7-chloro-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one)”.

Annotations

Footnotes

f1: S.R. 2002 No. 1, relevant amending Regulations are S.R. 2020 Nos. 104 and 73, S.R. 2019 Nos. 208 and 21, S.R. 2018 Nos. 173 and 4, S.R. 2016. No. 29, S.R. 2015 Nos. 227 and 53, S.R. 2014 Nos. 261, 158 and 21, S.R. 2013 No. 78, S.R. 2012 No. 213, S.R. 2011 No. 153, S.R. 2010 Nos. 247 and 148, S.R. 2009 No. 390, S.R. 2007 No. 348 and S.R. 2005 No. 360